质量控制频率:揭示真相
本研究使用QC Constellation工具进行基于风险的QC计算,探讨高敏肌钙蛋白(三个QC水平)和肌酐(两个QC水平)每日最佳QC事件数。测试四种QC规则方案和sigma值3至6,发现sigma值降低时最大运行批量减小、每日QC事件增加;高敏肌钙蛋白因潜在错误危害为灾难性需更频繁QC。结论认为分析性能和危害严重程度显著影响QC频率。
要点
- sigma值降低时最大运行批量减小、每日QC事件增加。
- 高敏肌钙蛋白因灾难性危害需比肌酐更频繁QC。
- 高危害分析物应追求更高sigma值以维持可行QC实践。
核心结论
- 分析性能和危害严重程度显著影响所需QC事件频率。
- 实验室设计QC策略需平衡患者安全与操作效率。
- 高危害分析物达到更高sigma值对维持可行且成本有效的QC实践至关重要。
- 结合基于风险和基于患者的混合QC方法可能优化QC策略,但sigma值计算标准化仍需推进。
研究设计与样本
- 使用QC Constellation工具进行基于风险的QC计算。
- 针对高敏肌钙蛋白(灾难性危害,三个QC水平)和肌酐(严重危害,两个QC水平)测试四种QC规则方案:1-3s、1-3s/2-2s、1-3s/2-2s/R-4s、1-3s/2-2s/R-4s/4-1s。
- 评估sigma值3至6以确定最大运行批量。
- 估计假设每日处理1000个样本的实验室的QC事件频率。
主要发现
- 最大运行批量随sigma值下降而减小。
- 每日QC事件数随sigma值下降而增加。
- 高敏肌钙蛋白因潜在错误相关灾难性危害需比肌酐更频繁QC。
关键数值与推荐
- 高敏肌钙蛋白使用三个QC水平,肌酐使用两个QC水平。
- 测试的QC规则方案包括1-3s、1-3s/2-2s、1-3s/2-2s/R-4s、1-3s/2-2s/R-4s/4-1s。
- 评估的sigma值范围为3至6。
- QC事件频率估计基于每日处理1000个样本的假设实验室。
临床怎么用
- 实验室设计QC策略时应同时考虑分析性能和危害严重程度。
- 对高危害分析物应追求更高sigma值以维持可行且成本有效的QC实践。
- 可考虑结合基于风险和基于患者的混合QC方法优化QC策略。
局限性
- sigma值计算标准化仍需推进。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study investigates the optimal number of quality control (QC) events per day in two scenarios: high-sensitive troponin, requiring three levels of QC materials, and creatinine, with two levels. The aim is to explore how different QC rules and sigma metric values affect the frequency of QC events, considering both analytical performance and the clinical impact of potential measurement errors as severity of harm. METHODS: Risk-based QC calculations were performed using the QC Constellation tool. Four QC rule schemes (1-3 s, 1-3 s/2-2 s, 1-3 s/2-2 s/R-4 s, 1-3 s/2-2 s/R-4 s/4-1 s) were tested for high-sensitive troponin (catastrophic harm) and creatinine (serious harm). Sigma metric values from 3 to 6 were evaluated to determine maximum run sizes. QC event frequency was estimated for a hypothetical laboratory processing 1,000 samples daily. RESULTS: Maximum run sizes decreased as sigma metric values declined. Correspondingly, the number of QC events per day increased as sigma metric values decreased. For high-sensitive troponin, with its catastrophic severity of harm related to potantial error, more frequent QC was necessary compared to creatinine. CONCLUSIONS: Analytical performance and severity of harm significantly influence the required frequency of QC events. Laboratories must consider both factors when designing QC strategies to balance patient safety with operational efficiency. For analytes with high severity of harm, achieving higher sigma metrics is critical to maintain feasible and cost-effective QC practices. A hybrid QC approach combining risk-based and patient-based methods may optimize QC strategies, but standardization of sigma metric calculations is still needed.
引用
- Can Çubukçu H. Quality control frequency: Unleashing the truth. Clin Chim Acta. 2024. PMID: 39645017. doi:10.1016/j.cca.2024.120068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。